UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 375

Sortiert nach

Chronic hepatitis B virus infection

The Lancet (British edition), 2018-11, Vol.392 (10161), p.2313-2324

2018

Link zum Volltext

Verfügbarkeit prüfen

Nonalcoholic fatty liver disease in Asia: emerging perspectives

Journal of Gastroenterology, 2017-02, Vol.52 (2), p.164-174

2017

Link zum Volltext

Verfügbarkeit prüfen

HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy

Hepatology (Baltimore, Md.), 2021-06, Vol.73 (6), p.2167-2179

2021

Link zum Volltext

Verfügbarkeit prüfen

Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”

Journal of hepatology, 2020-12, Vol.73 (6), p.1573-1574

2020

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

Gut and Liver, 2016, 10(3), , pp.332-339

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

The lancet oncology, 2011-06, Vol.12 (6), p.568-574

2011

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA

Liver international, 2017-07, Vol.37 (7), p.995-1001

2017

Link zum Volltext

Verfügbarkeit prüfen

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Alimentary pharmacology & therapeutics, 2020-04, Vol.51 (8), p.801-811

2020

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance

Hepatology (Baltimore, Md.), 2018-08, Vol.68 (2), p.462-472

2018

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

Journal of gastroenterology and hepatology, 2020-02, Vol.35 (2), p.320-325

2020

Link zum Volltext

Verfügbarkeit prüfen

Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B

Journal of hepatology, 2020-10, Vol.73 (4), p.800-806

2020

Link zum Volltext

Verfügbarkeit prüfen

Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years

Hepatology (Baltimore, Md.), 2017-10, Vol.66 (4), p.1036-1044

2017

Link zum Volltext

Verfügbarkeit prüfen

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

Gut, 2021-04, Vol.70 (4), p.775

2021

Link zum Volltext

Verfügbarkeit prüfen

Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis

Hepatology (Baltimore, Md.), 2023-05, Vol.77 (5), p.1735-1745

2023

Link zum Volltext

Verfügbarkeit prüfen

Chronic liver disease: Global perspectives and future challenges to delivering quality health care

PloS one, 2021-01, Vol.16 (1), p.e0243607-e0243607

2021

Link zum Volltext

Verfügbarkeit prüfen

Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data

Alimentary pharmacology & therapeutics, 2022-04, Vol.55 (8), p.921-943

2022

Link zum Volltext

Verfügbarkeit prüfen

What facilitates hepatitis B and hepatitis C testing and the role of stigma among primary care patients in China?

Journal of viral hepatitis, 2022-08, Vol.29 (8), p.637-645

2022

Link zum Volltext

Verfügbarkeit prüfen

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Hepatology international, 2020-01, Vol.14 (1), p.35-46

2020

Link zum Volltext

Verfügbarkeit prüfen

Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy

Journal of gastroenterology, 2021-05, Vol.56 (5), p.479-488

2021

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census

Liver international, 2015-02, Vol.35 (2), p.542-549

2015

Link zum Volltext

Verfügbarkeit prüfen

Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down‐regulating the nuclear factor‐kappa B signaling

Journal of digestive diseases, 2020-01, Vol.21 (1), p.38-45

2020

Link zum Volltext

Verfügbarkeit prüfen

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B

Clinical gastroenterology and hepatology, 2018-04, Vol.16 (4), p.575-583.e2

2018

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma

Journal of viral hepatitis, 2019-12, Vol.26 (12), p.1473-1480

2019

Link zum Volltext

Verfügbarkeit prüfen

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease

Liver international, 2020-11, Vol.40 (11), p.2719-2731

2020

Link zum Volltext

Verfügbarkeit prüfen

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes

Hepatology (Baltimore, Md.), 2023-02, Vol.77 (2), p.606-618

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 375

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(346)
Mit Volltextzugriff
(338)

Publikationsform

Sprache

Englisch
(347)
Japanisch
(44)
Koreanisch
(28)

Erscheinungsjahr

n.n

Thema

Science & Technology
(228)
Life Sciences & Biomedicine
(213)
Humans
(156)
Gastroenterology & Hepatology
(145)
Female
(96)
Male
(93)
Hepatitis B
(88)
Middle Aged
(86)
Adult
(75)
Hepatitis B Virus
(73)
Hepatitis
(64)
Hepatitis B, Chronic - Drug Therapy
(61)
Aged
(58)
Hepatology
(55)
Antiviral Agents - Therapeutic Use
(50)
Hepatitis B Virus - Genetics
(46)
Liver
(46)
Hepatocellular Carcinoma
(44)
Dna
(39)
Liver Cirrhosis
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(17)
... seit 30 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Chronic hepatitis B virus infection

Nonalcoholic fatty liver disease in Asia: emerging perspectives

HBV RNA Profiles in Patients With Chronic Hepatitis B Under Different Disease Phases and Antiviral Therapy

Letter regarding “A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement”

Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region

Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score

Hepatitis B virus core‐related antigen as a surrogate marker for covalently closed circular DNA

Modelling NAFLD disease burden in four Asian regions—2019‐2030

Long‐term outcomes and predictive scores for hepatocellular carcinoma and hepatitis B surface antigen seroclearance after hepatitis B e‐antigen seroclearance

Suboptimal treatment of dyslipidemia in patients with nonalcoholic fatty liver disease

Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B

Long‐term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years

Role of serum HBV RNA and hepatitis B surface antigen levels in identifying Asian patients with chronic hepatitis B suitable for entecavir cessation

Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis

Chronic liver disease: Global perspectives and future challenges to delivering quality health care

Review article: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data

What facilitates hepatitis B and hepatitis C testing and the role of stigma among primary care patients in China?

Use of HBsAg quantification in the natural history and treatment of chronic hepatitis B

Residual HBV DNA and pgRNA viraemia is associated with hepatocellular carcinoma in chronic hepatitis B patients on antiviral therapy

High prevalence of non-alcoholic fatty liver disease in the Chinese - results from the Hong Kong liver health census

Activation of adenosine A3 receptor inhibits inflammatory cytokine production in colonic mucosa of patients with ulcerative colitis by down‐regulating the nuclear factor‐kappa B signaling

Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B

Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma

Unhealthy lifestyle habits and physical inactivity among Asian patients with non‐alcoholic fatty liver disease

Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes

Suchergebnisse filtern